Metastatic Breast Cancer

Metastatic Breast Cancer

Stay informed on the latest news and clinical advances.

Circulating Tumor DNA Testing Shows Wide-Ranging Promise in Breast Cancer From breast cancer screening to detecting minimal residual disease after treatment, circulating tumor DNA testing has many promising applications in breast cancer management.
Medscape Oncology, April 11, 2018

AACR 2018 Olaparib in Breast Cancer: PFS Is Significant but OS Is Not New results from the OlympiAD trial show that overall survival was not significant, but a breast cancer expert says that this will not affect uptake of olaparib for these patients.
Medscape Medical News, April 18, 2018
Watson for Oncology and Breast Cancer Recommendations What is the level of concordance between the artificial intelligence clinical decision-support system Watson for Oncology and a breast cancer tumor board?
Annals of Oncology, April 6, 2018
Poly-ligand Profiling May Best Predict Response to Trastuzumab Poly-ligand profiling (PLP), a proprietary technology platform, has the potential to improve patient stratification for trastuzumab by predicting responders more accurately than standard testing, according to a proof-of-concept study.
Reuters Health Information, April 5, 2018
Breast Cancer Chemo Responders May Avoid Lymph Node Surgery Women with aggressive forms of breast cancer may be able to avoid lymph node surgery and its adverse effects if they respond well to chemotherapy, the results of two studies suggest.
Medscape Medical News, March 22, 2018

ctDNA Shows Wide-Ranging Promise in Breast Cancer From breast cancer screening to detecting minimal residual disease after treatment, circulating tumor DNA testing has many promising applications in breast cancer management.
Medscape Oncology, April 11, 2018
Beyond APHINITY: What Now After Pivotal Breast Cancer Trial? Dr Kathy Miller speaks with APHINITY's principal investigator about whether survival in HER2+ disease can be pushed even further.
Medscape Oncology, February 15, 2018

Depressed Mentation in a 52-Year-Old Woman A 52-year-old woman presents with a 5-day history of headaches and lethargy. The patient also complains of nausea and blurry vision. What's the diagnosis?
Medscape, January 12, 2018

Fast Five Quiz: Metastatic Breast Cancer Breast cancer remains the leading cause of cancer death among women worldwide. How much do you know about metastatic breast cancer? Test your knowledge with our short quiz.
Medscape, January 12, 2018

Renowned leaders offer insight on emerging research affecting the treatment and quality of life of patients with metastatic breast cancer.

Fatima F. Cardoso, MD, Director, Breast Unit, Champalimaud Clinical Centre, Lisbon, Portugal
Coordinator, Breast Cancer Program, European School of Oncology, Milan, Italy
Co-chair, Advanced Breast Cancer International Consensus Guidelines Conference
Ann H. Partridge, MD, MPH, Professor of Medicine, Harvard Medical School
Director, Adult Survivorship Program
Founder and Director, Program for Young Women With Breast Cancer
Vice Chair, Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts

Hope S. Rugo, MD, Professor of Medicine
Director, Breast Oncology and Clinical Trials Education
University of California San Francisco Medical Center, San Francisco, California

European Society for Medical Oncology (ESMO) Congress Read clinically focused news coverage of key developments from ESMO 2017.

American Society of Clinical Oncology (ASCO) Annual Meeting Read clinically focused news coverage of key developments from ASCO 2017.

San Antonio Breast Cancer Symposium (SABCS) 2016 Read clinically focused news coverage of key developments from SABCS 2016.

	Which treatment side effect is the biggest concern for your patients as they prepare to undergo treatment for metastatic breast cancer?
		Depression
		Hair loss
		Nausea/lack of appetite
		Fatigue